Exercise and GLP-1 considerations GLP-1 medications reduce caloric intake, which means you have less fuel available for exercise
The interventions in this article are not theoretical
These risks have been studied extensively, monitored, and are manageable through dose escalation protocols and patient education
The real challenge lies in keeping it off and maintaining a healthy balance over time
The conversation covers how our understanding of obesity as a chronic, relapsing disease has changed over the past 30 years, what the new clinical versus preclinical obesity framework means for how we diagnose and treat it, how GLP-1 drugs work and why they've succeeded where earlier medications failed, what the STEP and SELECT trials revealed about the disease-modifying potential of semaglutide, and how patients and clinicians should be thinking about who these drugs are really for
For constipation, the answer is: possibly, for some users, with the right strain and realistic expectations